These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25712936)

  • 21. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
    Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
    Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular calcification in patients with chronic kidney disease.
    Nitta K
    Ther Apher Dial; 2011 Dec; 15(6):513-21. PubMed ID: 22107687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
    Tatami Y; Yasuda Y; Suzuki S; Ishii H; Sawai A; Shibata Y; Ota T; Shibata K; Niwa M; Morimoto R; Hayashi M; Kato S; Maruyama S; Murohara T
    Atherosclerosis; 2015 Dec; 243(2):349-55. PubMed ID: 26519631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic kidney disease-a cardiovascular high-risk constellation].
    Speer T; Schunk SJ; Fliser D
    Internist (Berl); 2020 Apr; 61(4):340-348. PubMed ID: 31578597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical detection, risk factors, and cardiovascular consequences of medial arterial calcification: a pattern of vascular injury associated with aberrant mineral metabolism.
    Lau WL; Ix JH
    Semin Nephrol; 2013 Mar; 33(2):93-105. PubMed ID: 23465497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular calcification in chronic kidney disease: role of disordered mineral metabolism.
    Palit S; Kendrick J
    Curr Pharm Des; 2014; 20(37):5829-33. PubMed ID: 24533939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular calcifications in chronic kidney disease--clinical management.
    Checheriţă IA; Smarandache D; David C; Ciocâlteu A; Ion DA; Lascăr I
    Rom J Morphol Embryol; 2012; 53(1):7-13. PubMed ID: 22395493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs Are Associated with Uremic Toxicity, Cardiovascular Calcification, and Disease.
    Massy ZA; Metzinger-Le Meuth V; Metzinger L
    Contrib Nephrol; 2017; 189():160-168. PubMed ID: 27951581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular calcification in end stage renal disease.
    Raggi P
    Contrib Nephrol; 2005; 149():272-278. PubMed ID: 15876850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
    Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.
    Salem S; Bruck H; Bahlmann FH; Peter M; Passlick-Deetjen J; Kretschmer A; Steppan S; Volsek M; Kribben A; Nierhaus M; Jankowski V; Zidek W; Jankowski J
    Am J Nephrol; 2012; 35(1):31-9. PubMed ID: 22179063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of AGEs-RAGE system in CKD-MBD.].
    Fujisawa H; Nakayama Y; Ueda K; Fukami K
    Clin Calcium; 2019; 29(2):193-198. PubMed ID: 30679400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?
    Hildebrand S; Cunningham J
    Bone; 2021 Jan; 142():115751. PubMed ID: 33188959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease.
    Shigematsu T; Sonou T; Ohya M; Yokoyama K; Yoshida H; Yokoo T; Okuda K; Masumoto AR; Iwashita Y; Iseki K; Kunimoto S; Yamano Y
    Contrib Nephrol; 2017; 189():169-177. PubMed ID: 27951564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis and Management of Vascular Calcification in Patients with End-Stage Renal Disease.
    Ogawa T; Nitta K
    Contrib Nephrol; 2018; 196():71-77. PubMed ID: 30041207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
    Matsumoto T; Fukushima S; Kanasaki T; Hagino S
    Biol Trace Elem Res; 2012 Dec; 150(1-3):278-84. PubMed ID: 22700181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.
    Brandenburg VM; D'Haese P; Deck A; Mekahli D; Meijers B; Neven E; Evenepoel P
    Pediatr Nephrol; 2016 Feb; 31(2):195-206. PubMed ID: 25735207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnesium and cardiovascular complications of chronic kidney disease.
    Massy ZA; Drüeke TB
    Nat Rev Nephrol; 2015 Jul; 11(7):432-42. PubMed ID: 25963594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.